World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
53504
World Ranking
11956
National Ranking
1133

Overview

Juan W. Valle is affiliated with the University of Manchester in the United Kingdom and has a substantial body of work in the field of medicine, with a focus on oncology. Their research contributions span multiple subfields including oncology, surgery, pulmonary and respiratory medicine, epidemiology, and cancer research.

Their main research topics cover several areas within cancer studies, such as:

  • Cholangiocarcinoma and gallbladder cancer studies
  • Pancreatic and hepatic oncology research
  • Neuroendocrine tumor research advances
  • Gallbladder and bile duct disorders
  • Lung cancer research studies
  • Neuroblastoma research and treatments
  • Cancer genomics and diagnostics

Juan W. Valle has contributed to several recent papers in prominent journals, including:

  • Biliary tract cancer, 2021, The Lancet
  • Pancreatic cancer, 2020, The Lancet
  • Cholangiocarcinoma 2020: the next horizon in mechanisms and management, 2020, Nature Reviews Gastroenterology & Hepatology
  • Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study, 2020, The Lancet Oncology
  • Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer, 2022, NEJM Evidence

The venues where Juan W. Valle frequently publishes include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Cancers
  • Journal of Hepatology
  • British Journal of Cancer

Co-authorship is an important aspect of Juan W. Valle's research activity. They have frequently collaborated with:

  • Ángela Lamarca
  • Mairéad G. McNamara
  • Richard Hubner
  • John Bridgewater
  • Robin Kate Kelley

The overall publication record reflects a focus on clinical and experimental oncology, with a particular emphasis on cancers of the biliary tract, pancreas, and related organ systems. The combination of research topics, collaborative network, and publication venues situates Juan W. Valle within an active scientific community dedicated to advancing understanding and management of complex cancer types.

Best Publications

  • Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

    Juan Ignacio Valle;Harpreet Singh Wasan;Daniel H Palmer;David Cunningham

  • Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

    Eric Raymond;Laetitia Dahan;Jean Luc Raoul;Yung Jue Bang

  • Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

    John P. Neoptolemos;John P. Neoptolemos;Daniel H. Palmer;Daniel H. Palmer;Paula Ghaneh;Eftychia E. Psarelli

  • Cholangiocarcinoma 2020: the next horizon in mechanisms and management

    Jesus M. Banales;Jesus M. Banales;Jesus M. Banales;Jose J. G. Marin;Jose J. G. Marin;Angela Lamarca;Angela Lamarca;Pedro M. Rodrigues

  • Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial

    John P. Neoptolemos;Deborah D. Stocken;Claudio Bassi;Paula Ghaneh

  • Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

    James C. Yao;Nicola Fazio;Simron Singh;Roberto Buzzoni

  • Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

    John N Primrose;Richard P Fox;Daniel H Palmer;Hassan Z Malik

  • Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer

    David Cunningham;Ian Chau;Deborah D. Stocken;Juan W. Valle

  • Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

    John K Ramage;A Ahmed;J Ardill;N Bax

  • Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

    Ghassan K. Abou-Alfa;Ghassan K. Abou-Alfa;Teresa Macarulla;Milind M. Javle;Robin K. Kelley

  • Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.

    Angela Lamarca;Daniel H Palmer;Harpreet Singh Wasan;Paul J Ross

  • Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer

    P J Ross;Marianne Nicolson;David Cunningham;Juan W Valle

  • Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    J W Valle;Ivan Borbath;S A Khan;F Huguet

  • Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.

    John P. Neoptolemos;Malcolm J. Moore;Trevor F. Cox;Juan W. Valle

  • Biliary tract cancer

    Juan W. Valle;Juan W. Valle;R. Katie Kelley;Bruno Nervi;Do Youn Oh

  • New Horizons for Precision Medicine in Biliary Tract Cancers

    Juan W. Valle;Angela Lamarca;Lipika Goyal;Jorge Barriuso

  • Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial

    J Primrose;S Falk;M Finch-Jones;Juan W Valle

  • Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study

    Juan W. Valle;Daniel Palmer;Richard Jackson;Trevor Cox

  • Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

    Juan W Valle;J Furuse;M Jitlal;S Beare

  • Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

    JP Neoptolemos;MJ Moore;TF Cox;JW Valle

Frequent Co-Authors

David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust
John P. Neoptolemos
John P. Neoptolemos Heidelberg University
Matthew H. Kulke
Matthew H. Kulke Boston Medical Center
Tim Meyer
Tim Meyer University College London
Ghassan K. Abou-Alfa
Ghassan K. Abou-Alfa Memorial Sloan Kettering Cancer Center
Eric Raymond
Eric Raymond St. Joseph Hospital
Arndt Vogel
Arndt Vogel Hannover Medical School
Caroline Dive
Caroline Dive University of Manchester
Bengt Glimelius
Bengt Glimelius Uppsala University
Jean-Luc Raoul
Jean-Luc Raoul Institut de Cancérologie de l'Ouest (ICO)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The medical field offers diverse online degree programs that can open doors to new career opportunities or expand current skills. If you are a registered nurse interested in becoming a nurse practitioner, there are rn to np bridge programs designed to streamline the process and minimize time spent in traditional classrooms.

For those drawn to preventative health and wellness, a bachelor's in nutrition online can provide foundational knowledge in dietetics and open pathways in both clinical and community health careers.

Aspiring healthcare administrators may benefit from enrolling in a cahme accredited online mha program. This can help build expertise in leadership, healthcare policy, and strategic management—skills crucial for advancing in healthcare management roles.

Additionally, working nurses seeking to further their education might consider an online rn to bsn no clinicals program, which can offer flexibility and eliminate the need for added on-site clinicals.

Best Scientists Citing Juan W. Valle

Trending Scientists

Recently Published Articles